Marvell Technology (MRVL) News Today

Shares of Marvell Technology, Inc. (NASDAQ:MRVL) have increased following a series of strategic AI chip contract wins and widespread analyst upgrades.

• Marvell secured two new large-scale AI ASIC design wins, expanding its custom silicon pipeline to 13 programs and projecting multi-billion-dollar revenue opportunities in 2026–27.
• Major Wall Street firms including Bank of America and B. Riley boosted their price targets to $90 and $115, respectively, after Marvell’s AI-focused event and raised earnings forecasts.
• B. Riley increased its Q3 2026 EPS estimate to $0.56 (from $0.55), reaffirmed a Buy rating, and lifted longer-term earnings and price objectives.
• Marvell announced a dividend initiative, which helped drive shares higher as income-seeking investors responded positively.
• Analysts at Rosenblatt, Benchmark, Needham and others reiterated Buy ratings with price targets ranging from $85 to $124, citing Marvell’s strong strategic positioning in AI and data-center markets.
• Zacks Research raised its Q2 2026 EPS projection to $0.51 (up from $0.46), reflecting accelerating margin expansion.
• Unusual call-options activity spiked after Marvell reported strong quarterly results, signaling institutional confidence in the company’s growth trajectory.
• Partnership announcements, such as the deal with Empower and an expanded data-center outlook, reinforced Marvell’s sustainable growth strategy.
• Cantor Fitzgerald and Melius Research lifted price targets to $75 and $76 but maintained Neutral/Hold ratings, indicating limited near-term upside from current levels.
• Broader equity market tailwinds provided additional support for semiconductor stocks, including MRVL, amid a Fed-focused rally.
• SWOT analyses acknowledged Marvell’s strong AI roadmap but noted ongoing industry-wide competitive pressures.
• A comparative note highlighted competitor Credo Technology’s faster revenue growth and expanding AI-focused product lines, suggesting Marvell faces heightened competition.
• A Q1 performance review by Hardman Johnston pointed to returns lagging the S&P 500 Total Return Index, underscoring execution risks.